Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.
For an all-comer population with any impairment of LV function, an interarterial shunt device missed the primary endpoint in RELIEVE-HF, but benefit was seen with LVEF less than 40%.
A personal approach to outpatient cardiac rehab phillyvoice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phillyvoice.com Daily Mail and Mail on Sunday newspapers.
Tower Health Announces Rohinton Morris, MD, as New Chief of Cardiothoracic Surgery bctv.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bctv.org Daily Mail and Mail on Sunday newspapers.